🇺🇸 FDA
Pipeline program

PTM 75 mg Tablets, GS-1427, GS-1427, PTM 100 mg Tablets, GS-1427, PTM 25 mg Tablets

GS-US-409-5704

Phase 2 small_molecule active

Quick answer

PTM 75 mg Tablets, GS-1427, GS-1427, PTM 100 mg Tablets, GS-1427, PTM 25 mg Tablets for Ulcerative Colitis (UC) is a Phase 2 program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences International Limited
Indication
Ulcerative Colitis (UC)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials